The emergence of novel psychoactive substances presents a unique opportunity for researchers and policymakers alike. Among these, 2-FDCK has emerged prominence as a potent dissociative agent with unknown pharmacological properties. Preliminary studies suggest that 2-FDCK may induce analogous effects to other dissociatives, such as ketamine, but its